FDA grants Breakthrough Device Designation to GeneDx genome and exome tests supporting diagnosis of life-threatening genetic disorders. The FDA has granted Breakthrough Device Designation to GeneDx’s ...
Designation highlights GeneDx innovation in clinical whole genome and whole exome testing and accelerates the pathway for FDA authorization of these novel diagnostic tests GeneDx (Nasdaq: WGS), a ...
When it came time to start a family, Sarah Elizabeth Orlando, 33, knew she would go about it differently. Before she was born, an in-utero amniocentesis had confirmed she carried the gene for fragile ...
The proportion of children receiving genetic testing was highest for children with both autism spectrum disorder and intellectual disability. Tashalee R. Brown, M.D., Ph.D., from the University of ...
The proportion of children receiving genetic testing was highest for children with both autism spectrum disorder and intellectual disability. HealthDay News — Clinical implementation of genetic ...
Background: Balanced translocations are common chromosomal structural abnormalities that usually do not involve a gain or loss of genetic material; and carriers usually display normal phenotypes and ...
Objectives Current evidence recommend Microarray testing as first-tier investigation for Children with developmental Delay and moderate to severe intellectual disability. Our aim is to see the ...
Of the final sample, 31% of patients received at least one genetic test overall, but only 11% received concordant testing and at least one other test. The current study explored the role of genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback